| December 1, 2022 | | | 董事會命令 | |
| | | |
/s/ Joel Shulman
Joel Shulman
董事長兼首席執行官 |
|
| December 1, 2022 | | | 董事會命令 | |
| | | |
/s/ Joel Shulman
Joel Shulman
董事長兼首席執行官 |
|
| | |
Page
|
| |||
有關會議的問答
|
| | | | 1 | | |
前瞻性陳述
|
| | | | 12 | | |
RISK FACTORS
|
| | | | 13 | | |
BACKGROUND
|
| | | | 16 | | |
THE MEETING
|
| | | | 17 | | |
提案一 - 延期修正案提案
|
| | | | 20 | | |
提案二 - 董事選舉提案
|
| | | | 26 | | |
提案三 - 休會提案
|
| | | | 27 | | |
美國聯邦所得税考慮因素
|
| | | | 28 | | |
董事、高管和公司治理
|
| | | | 32 | | |
某些關係和關聯方交易
|
| | | | 40 | | |
證券的實益所有權
|
| | | | 42 | | |
股東提案
|
| | | | 44 | | |
房屋寄存信息
|
| | | | 44 | | |
您可以在哪裏找到更多信息
|
| | | | 44 | | |
附件A - 對修訂和重述的ApeIron資本投資公司公司註冊證書的擬議修正案。
|
| | | | A-1 | | |
Name
|
| |
Age
|
| |
Position
|
|
Dr. Joel Shulman | | |
55
|
| | 董事長兼首席執行官 | |
Eva Adosoglou | | |
31
|
| | 首席運營官 | |
Grant Grigorian | | |
59
|
| | 首席財務官 | |
Kevin Cramton | | |
61
|
| | Director | |
Charles Aggouras | | |
55
|
| | Director | |
Jeffrey Mortimer | | |
57
|
| | Director | |
| | |
Class A Common Stock
|
| |
Class B Common Stock
|
| |
Approximate
Percentage of Outstanding Common Stock |
| |||||||||||||||||||||
受益人姓名和地址(1)
|
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| ||||||||||||||||||
ApeIron Capital贊助商,LLC(2)
|
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Joel Shulman(3)
|
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Eva Adosoglou(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Grant Grigorian(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Kevin Cramton(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Charles Aggouras(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Jeffrey Mortimer(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
所有高管和董事作為一個羣體
(six individuals) |
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Other 5% Stockholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Highbridge Capital Management,LLC(4)
|
| | | | 1,179,474 | | | | | | 6.84% | | | | | | — | | | | | | — | | | | | | 5.5% | | |
卡拉莫斯市場中性收益基金(5)
|
| | | | 1,000,000 | | | | | | 5.8% | | | | | | — | | | | | | — | | | | | | 4.6% | | |
Saba Capital Management L.P.(6)
|
| | | | 1,300,000 | | | | | | 7.5% | | | | | | — | | | | | | — | | | | | | 6.0% | | |
| | | | ApeIron資本投資公司 | |
| | | |
By:
|
|
| | | | Name: Dr. Joel Shulman | |
| | | | 職務:首席執行官 | |